Bandhan Mutual Fund increased its stake in AstraZeneca Pharma India Limited from 1.13% to 1.50%, purchasing 93,351 shares.
A pharmaceutical manufacturer and distributor operating across India, AstraZeneca Pharma India engages in the production, distribution, and marketing of medicines spanning multiple therapeutic areas. The company serves hospitals, clinics, and retail pharmacies through its extensive distribution network and manufacturing facilities. Its core operations focus on delivering quality pharmaceutical products and treatments to healthcare providers and patients nationwide.
Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.
